- Open Access
T1-mapping in the heart: accuracy and precision
© Kellman and Hansen; licensee BioMed Central Ltd. 2014
- Received: 28 November 2013
- Accepted: 24 December 2013
- Published: 4 January 2014
The longitudinal relaxation time constant (T1) of the myocardium is altered in various disease states due to increased water content or other changes to the local molecular environment. Changes in both native T1 and T1 following administration of gadolinium (Gd) based contrast agents are considered important biomarkers and multiple methods have been suggested for quantifying myocardial T1 in vivo. Characterization of the native T1 of myocardial tissue may be used to detect and assess various cardiomyopathies while measurement of T1 with extracellular Gd based contrast agents provides additional information about the extracellular volume (ECV) fraction. The latter is particularly valuable for more diffuse diseases that are more challenging to detect using conventional late gadolinium enhancement (LGE). Both T1 and ECV measures have been shown to have important prognostic significance.
T1-mapping has the potential to detect and quantify diffuse fibrosis at an early stage provided that the measurements have adequate reproducibility. Inversion recovery methods such as MOLLI have excellent precision and are highly reproducible when using tightly controlled protocols. The MOLLI method is widely available and is relatively mature. The accuracy of inversion recovery techniques is affected significantly by magnetization transfer (MT). Despite this, the estimate of apparent T1 using inversion recovery is a sensitive measure, which has been demonstrated to be a useful tool in characterizing tissue and discriminating disease. Saturation recovery methods have the potential to provide a more accurate measurement of T1 that is less sensitive to MT as well as other factors. Saturation recovery techniques are, however, noisier and somewhat more artifact prone and have not demonstrated the same level of reproducibility at this point in time.
This review article focuses on the technical aspects of key T1-mapping methods and imaging protocols and describes their limitations including the factors that influence their accuracy, precision, and reproducibility.
- T1 map
- Cardiovascular magnetic resonance
The longitudinal relaxation time constant (T1) of the myocardium is altered in various disease states due to increased water content or other changes to the local molecular environment. Changes in both native T1 and T1 following administration of gadolinium (Gd) based contrast agents are considered important biomarkers and multiple methods have been suggested for quantifying myocardial T1 in vivo . Characterization of the native T1 of myocardial tissue may be used to detect and assess various cardiomyopathies while measurement of T1 with extracellular Gd based contrast agents provides additional information about the extracellular volume (ECV) fraction. The latter is particularly valuable for more diffuse diseases that are more challenging to detect using conventional late gadolinium enhancement (LGE). A number of recent papers have highlighted applications of T1-mapping in cardiovascular magnetic resonance (CMR) and their potential for detecting diffuse cardiomyopathies. Both T1 and ECV measures have been shown to have important prognostic significance [2, 3].
Late gadolinium enhancement (LGE) is currently the primary tool for tissue characterization in CMR and provides excellent depiction of myocardial infarction (MI) and focal scar, and has become an accepted standard for assessing myocardial viability . LGE is also useful for detecting and characterizing fibrosis that is “patchy” in appearance, e.g. as seen in non-ischemic cardiomyopathies such hypertrophic cardiomyopathy (HCM) . Diffuse myocardial fibrosis is, however, more difficult to distinguish using LGE since the myocardial signal intensity may be nearly isointense and may be globally “nulled” thus appearing to be normal tissue . Alternatively, quantitative measurement of myocardial T1 following administration of an extracellular Gadolinium-based contrast agent has been shown to be sensitive to increased extracellular volume associated with diffuse myocardial fibrosis. However, a single post-contrast T1 measurement has limitations due to a variety of confounding factors [7, 8] such as gadolinium clearance rate, time of measurement, injected dose, body composition, and hematocrit. These factors cause a significant variation in post-contrast T1 making it difficult to distinguish diseased and normal tissue based on absolute T1 values alone. Pre-contrast T1 varies with water content and may be elevated in cases of diffuse myocardial fibrosis. Pre-contrast T1 also varies significantly with field strength . Direct measurement of extracellular volume (ECV) was initially developed for quantifying the myocardial extracellular fractional distribution volume  and has been proposed as a means for detection and quantification of diffuse myocardial fibrosis [6, 11–18]. This approach is based on the change in T1 following administration of an extracellular contrast agent and circumvents the limitation of a single post-contrast T1 measurement in detecting a global change in T1. Myocardial ECV is measured as the percent of tissue comprised of extracellular space, which is a physiologically intuitive unit of measurement and is independent of field strength. ECV has been shown to correlate with collagen volume fraction in some diseases [12, 13].
Native T1-mapping as well as ECV mapping is currently being explored as a diagnostic tool for a wide range of cardiomyopathies. Native T1 changes are detectable in both acute and chronic MI [19, 20], and may be used to characterize the edematous area at risk [21–23]. Elevated native T1 has also been reported in a number of diseases with cardiac involvement: myocarditis , amyloidosis , lupus , system capillary leakage syndrome , and decreases in native T1 have been associated with Anderson Fabry disease , and high iron content [28, 29].
In general, methods for measuring myocardial T1 consists of three components: 1) a perturbation of the longitudinal magnetization (i.e. an inversion or saturation), 2) an experiment to sample the relaxation curve as the longitudinal magnetization returns to its original level, and 3) a model used to fit the sampled curve and extract the myocardial T1. This paper focuses on the technical aspects of key methods and imaging protocols and describes their limitations and the factors that influence their accuracy, precision, and reproducibility. The accuracy and precision of these measurements affect the detection and quantification of abnormal myocardial tissue.
The sensitivity for detecting abnormal elevation of T1 and ECV is fundamentally limited by the precision of T1 estimates, which is a function of the number and timing of measurements along the inversion- or saturation-recovery curve, the signal-to-noise ratio (SNR), the tissue T1, and the method of fitting. Other factors that may not be random may also introduce errors that further limit the reproducibility. To successfully optimize imaging protocols, it is beneficial to understand the factors that influence the measurement accuracy.
A consensus statement by the T1-mapping working group  provides a general framework of recommendations. Well-controlled and optimized protocols are key to reproducibility, which is particularly important in applications aiming at detection of subtle fibrosis and pre-clinical disease. It is important to understand artifact mechanisms in parametric mapping which may be less familiar than conventional CMR artifact mechanisms.
Brief history of methods for T1-mapping in the heart
Methods for measuring myocardial T1 were initially based on region of interest (ROI) analysis rather than pixel-wise parametric maps. Inversion recovery images at different inversion times were acquired with multiple breath-holds  or inversion recovery cine protocols were used as a means of acquiring data in a single breath-hold . These early methods were ROI based schemes and were not suitable for pixel-wise mapping. Pixel-wise T1-mapping first appeared on the scene with the introduction of the MOLLI imaging strategy , which propelled the use of T1-mapping in CMR and inspired many new methods. MOLLI is widely used today with some protocol optimization and other adaptations. A shortened breath-hold adaptation with conditional curve fitting (ShMOLLI)  was proposed as a means of mitigating heart rate dependence as well as shortening the breath-hold. Further protocol optimization has been aimed at shortening the breath-hold and optimizing precision [15, 34]. Motion correction was developed to mitigate respiratory motion for subjects with poor breath-holding  and phase sensitive inversion recovery reconstruction with motion correction further improved image quality . A number of publications analyzed the accuracy of T1 measurements [32, 33, 37–42] leading to a better understanding of the influence of various protocol parameters on T1-measurement errors. Saturation recovery methods that were developed initially for T1-measurements during first pass contrast enhanced perfusion (SAP-T1)  have been recently adapted for T1-mapping using SSFP readout (SASHA)  as a means of mitigating the T1-underestimation in MOLLI. Even more recently, hybrid schemes have been proposed that incorporate both inversion and saturation recovery methods (SAPPHIRE) . ECV measurements were initially introduced using ROI based measurement [10–12] and pixel-wise ECV mapping was later introduced [16, 34]. Improvements to T1- and ECV-mapping are continuously introduced, and this review provides a snapshot of the current state-of-the-art from our perspective.
This paper reviews the basic concepts behind the widely used MOLLI and SASHA acquisition strategies for T1-mapping, followed by a review of factors influencing accuracy and precision. Discussion includes a description of other limitations and a summary of pros and cons of various protocols.
Acquisition strategies and protocols
The analytic relationship between T1* and T1 for SSFP has been derived for continuous SSFP under somewhat idealized conditions such as ideal slice profile . Useful analytic derivations for gated SSFP with realistic slice profiles have not been developed due to complexity. Bloch simulations may be used to calculate the error inherent in this approximation  and to gain insight into the sensitivity of various protocol parameters and design variables. The influence of various parameters on accuracy is provided in following Sections.
The SASHA method acquires multiple time points on the SR curve and does a pixel-wise curve fit. In order to acquire a fully recovered image, an image is initially acquired prior to any saturation preparation, i.e., starting from the equilibrium magnetization. Images are acquired on successive heart beats using SR preparations with varying trigger delays. In the original proposed SASHA protocol there are 10 images acquired at saturation delays uniformly spaced over the RR-interval plus the initial fully recovered image which serves as an important anchor point for the curve fit. The order in which the various delays are acquired is not of significant importance for fitting assuming ideal saturation. Importantly, the SR curve recovers as T1 and is not influenced by the readout so that it is not shortened to an apparent T1* < T1 as in the case of MOLLI. Therefore, no correction is necessary, which eliminates the source of many inaccuracies of the IR based MOLLI scheme. Since the readout does not lead to an apparent T1*, a higher flip angle readout is possible which makes up for some of the lost dynamic range in using SR. The higher readout flip angle readout using SSFP with linear phase encode ordering does slightly alter the shape of the recovery curve causing an apparent bias, i.e., curve does not start at 0 for 0 delay. Thus, the otherwise 2-parameter signal model S(t) = A(1- exp(−t/T1)) for SR assuming ideal saturation, becomes a 3-parameter model S(t) = A – B exp(−t/T1). The 3-parameter model also absorbs any imperfection in the saturation efficiency due to the RF saturation pulse. However, the cost of estimating the additional parameter leads to a loss of precision. Therefore, as in all things, there is a trade-off between accuracy and precision in considering whether to use 2 or 3-parameter fitting, which is analyzed in more detail in the following. Although a center-out phase encode order in which the center of k-space is acquired first has the potential to completely remove the influence of the readout, the use of center out ordering with SSFP is problematic due to artifacts and the use of center-out FLASH is associated with a significant loss of SNR.
The SASHA sampling scheme may be altered to acquire longer saturation delay measurements by allowing 1 or more heart beat recovery periods between saturations. However, measurements cannot be made during the recovery periods without distorting the curve, thus additional measurements reduce the overall SNR efficiency somewhat. Schemes that simply use a MOLLI strategy replaced with SR  incur the problems of an apparent T1* without gaining the main benefits of SR. A combined IR/SR approach known as SAturation Pulse Prepared Heart rate independent Inversion-REcovery (SAPPHIRE)  gains many of the benefits of IR and SR but still retain some of the problems associated with IR. Each method has its strengths and weaknesses in terms of accuracy, precision, and overall reproducibility, which are examined in greater detail in the following.
Accuracy: systematic errors and biases
Factors influencing the accuracy of T1-measurement using inversion and/or saturation recovery methods
• Underestimation in T1 depends on the protocol parameters
• Precision depends on the sampling strategy
Echo-spacing (BW & TR)
• Partial volume errors depend on the spatial resolution and slice thickness
# images & acquisition strategy
• T1 measurement accuracy is influenced by the sequence design
Inversion pulse efficiency & BW
SSFP steady state run-up
• Off-resonance causes both regional and global underestimation of T1
Center frequency adjustment
• Short z-FOV influences recovery time for inflowing blood
B1 transmit ampl (flip angle)
• Scan to scan variation affects reproducibility
2 vs 3 parameters
• Fitting additional parameters worsens precision
Multi-fit MagIR vs PSIR
• Tissue characteristics influence the apparent inversion recovery
• Partial volume effects are an artifact and may contaminate measurements
• Loss of spatial resolution due to motion increases the partial volume problem
Many of the errors in the MOLLI scheme which uses inversion recovery with SSFP readout are a result of the approximation of the so called Look-Locker correction which attempts to correct for the fact that the apparent T1-recovery time is less than the true recovery time. The apparent T1* shortening is T2-dependent as a consequence of the SSFP behavior [33, 37–39, 44]. This error leads to a series of dependencies such as heart rate dependence and sensitivity to off-resonance, which will be described in the following paragraphs. Interdependence of parameters makes it difficult to neatly describe the performance. In this discussion, we begin with a set of nominal parameters and examine deviations of a single parameter such as heart rate, off-resonance, or flip angle to gain insight into the sensitivity of that specific parameter.
The calculation of T1-errors in this article is based on waveform level Bloch-simulations and curve fitting using the following MOLLI and SASHA protocols. Existing studies in the literature rely heavily on simulations but are difficult to compare directly as a result of different assumed protocol parameters (e.g., slice profile) or methodology of simulation. To simplify comparisons, all analysis presented here use common methods and assumptions. The SSFP readout used a 480 μs low time-bandwidth product Hamming weighted sinc pulse with ≈ 8 mm slice thickness, and TR = 2.8 ms (bandwidth 1085 Hz/pixel), and 5 pulses with linear ramp flip angle to catalyze toward steady state. The matrix (256×144) assumed parallel imaging with factor 2 acceleration, separate reference lines, and partial Fourier factor of 7/8 in the phase encoding direction. The actual number of phase encodes was 63 with center at line 27. MOLLI used a tan/tanh adiabatic inversion  with 2.56 ms duration, and SASHA used an adiabatic BIR4-90 with 5.12 ms duration. Excitation flip angles were 35° and 70° for MOLLI and SASHA, respectively, unless otherwise noted. MOLLI used a minimum TI of 100 ms, and TI increment of 80 ms. SASHA acquired a fully recovered image plus 10 additional images acquired with saturation times spaced uniformly over the RR interval with minimum “inversion” time of 100 ms. MOLLI used PSIR 3-parameter curve fitting, and SASHA used both a 3-parameter fitting as originally proposed  as well as 2-parameter fitting as introduced here. Other parameters such as MOLLI sampling scheme (e.g. 5(3s)3), tissue, off-resonance, and heart rate were variable as indicated. In-vivo measurements were acquired on both 1.5 T (Siemens Magnetom Aera) and 3 T (Siemens Magnetom Skyra) MRI clinical scanners. In-vivo data presented here was acquired under a study protocol approved by the local Institutional Review Board and all subjects gave written informed consent.
Sensitivity to T2
Influence of off-resonance
Off-resonance is well known to cause banding artifacts using SSFP readout. It is not well appreciated, however, that a significant error in T1 may result at relatively small off-resonance frequencies that are well within the region without banding artifacts . Regional variations due to the inability to completely shim the B0-field variation around the heart may appear as regional variation in T1 that is artifactual. Although shimming problems are more of an issue at higher field strengths, the variation at 1.5 T is significant enough to be of concern particularly if it is not recognized. In a small study, the off-resonance frequency (after localized shimming) in the LV was measured across n = 18 subjects to have a mean value of 20.3 ± 13.0Hz at 1.5 and 15.4 ± 29.3Hz at 3 T, and to have maximum off-resonance of 61.8 ± 15.5 Hz at 1.5 T and 125.0 ± 40.6 Hz at 3 T . At 1.5 T, off-resonance greater than 80 Hz was observed in 4 of 18 subjects, which resulted in more significant T1 errors (> 3%) that could be erroneously interpreted as subtle regional variation of apparent T1 . Previous analysis of off-resonance related T1 errors in MOLLI  considered a smaller off-resonance (<50 Hz) frequencies which lead to minor errors. Previous analysis of off-resonance in SASHA only considered 3-parameter fitting ; here the simulations are expanded to include 2-parameter fitting for SASHA.
Influence of heart rate
The time between inversions may be increased by simply changing the order of inversions used in the sampling strategy. The original sampling strategy 3(3)3(3)5 acquired 11 images in 17 heart beats with 3 inversions. The spacing between inversions was 6 heart beats which meant that at higher heart rates the magnetization was not fully recovered for subsequent inversions. A 5(3)3 strategy which acquires 8 images in 11 heartbeats using 2 inversions has significantly improved heart rate sensitivity by increasing the spacing between inversions from 6 to 8 beats . This protocol evolved further to modify the recovery to be determined in seconds , 5(3s)3, and subsequently both acquisition and recovery to be determined in seconds (introduced here), 5s(3s)3s to ensure more complete recovery at high heart rates (> 60 bpm).
An alternative strategy to mitigate the heart rate sensitivity known as ShMOLLI  acquires using a 5(1)1(1)1 sampling scheme and performs conditional processing to discard the latter measurements for long T1 at high heart rates. In this scheme, 7 images are acquired in 9 heart beats with 3 inversions. For pixels with long T1 measured with short RR interval the data is re-fit using only the first 5 measurement of the 1st inversion. This mitigates a large source of heart rate sensitivity, although there is a significant loss of precision associated with discarding data.
By eliminating the problem with multiple inversions at high heart rate, there still remains a few percent heart rate sensitivity due to the influence of the SSFP readout. This may be further reduced by decreasing the SSFP readout excitation flip angle at the expense of SNR. Note that it is possible to improve the accuracy for the lower range of T1s associated with use of Gd contrast agents (200–600 ms) by selecting a protocol with better sampling strategy such as 4s(1s)3s(1s)2s. This will also improve the measurement precision for short T1 as discussed later.
It is worth remarking that a number of early studies did simulations and phantom measurement over a range of T1 values > 2000 ms to account for blood as well as myocardium. While this is relevant for measurement in stationary phantoms, it turns out that the blood flow eliminates the beat-to-beat influence of the readout and therefore completely alters the error mechanism in T1 inversion recovery measurements. For this reason we believe that the estimation of T1 in flowing blood should be treated separately from the myocardium and long T1 values associated with blood are not relevant in the discussion of heart rate sensitivity.
Influence of flip angle
The transmit flip angle will vary due to the accuracy of transmitter calibration and will vary spatially due to inhomogeneity of the B1+ field. Variation in transmit flip angle across the heart is estimated to be 25% at 1.5 T, so this issue is not unique to higher field strengths. The variation in flip angle affects both the SSFP readout and the IR/SR preparation. The influence of the flip angle error due to SSFP readout is approximately a couple of percent. For instance at a T1 = 1200 ms, if there is a variation in flip angle from 28 to 35 degrees, the error will range from −40 to −60 ms, or an apparent variation in T1 of 20 ms (1.7%).
The SNR is related to the steady state magnetization, which varies with flip angle. The transverse magnetization in the native myocardium for the fully recovered image is almost double for SASHA using a 70° SSFP readout compared with MOLLI with 35° SSFP readout which helps to compensate to some extent for the loss inherent in SR compared with IR.
The performance of the IR and SR preparation pulses must be robust to the expected variation of B1+ field or the error may be potentially quite large. Adiabatic inversion and saturation pulses may be designed for this purpose to ensure that the sensitivity to flip angle is minimized  as discussed next.
Influence of non-ideal inversion efficiency or saturation
Saturation recovery methods rely on a high degree of saturation to achieve accurate estimates of T1 . Methods such as SASHA are less sensitive to the degree of saturation if they use a 3-parameter signal model, which can absorb the non-ideal saturation to some extent along with the effect of the readout . However, the 2-parameter model is highly sensitive to imperfect saturation. SR preparations that use a pulse sequel with crushers [44, 49] are not adequate for use with 2-parameter fits. Using a BIR4-90 adiabatic pulse design optimized for saturation of the myocardium it is possible to achieve < 0.5% residual longitudinal magnetization over a 25% amplitude uncertainty and ±100 Hz uncertainty due to B0 variation.
Fitting model and number of parameters
Saturation recovery with ideal saturation is still based on a 3-parameter model (original proposed SASHA method) due to the influence of the readout . Here, we also consider using a 2-parameter fit with SASHA. As shown in the simulations, this can greatly reduce the random error but introduces susceptibility to biases caused by imperfect saturation and due to influences of the SSFP readout. While the 3-parameter model is most accurate, the 2-parameter model underestimates the T1 by approximately 3-4% even with ideal saturation.
The value of blood T1 is used mainly for calibrating the extra-cellular volume (ECV) fraction [10–12, 15, 16, 34]. Fortunately, the in-flow effect mainly affects the longer native T1 and is much less important for the measurement of T1 with contrast. The error in ΔR1 used for ECV calculation is less affected by errors in the pre-contrast T1. The acquisition of MOLLI images for a fixed time interval specified in seconds rather than a fixed number of beats ensures that the inversion recovery curve is sampled adequately (i.e., full recovery) even at high heart rates.
Due to the fact that the blood has different characteristics and is influenced differently than the myocardium, it is advantageous to apply different fitting procedures for myocardium and blood. Values for T1 of the blood are used primarily in the calculation of ECV. Although a single map is produced from a single experiment, blood T1 values used in ECV calculation may be estimated more precisely by fitting to measurements averaged over a ROI. A 3-parameter fit without correction maybe used since there is no significant beat-to-beat influence.
Spatial resolution and partial volume
Spatial resolution is particularly important in T1-mapping. The T1-mapping methods assume that the voxel is comprised of a single tissue species, e.g., myocardium or blood, and not a mixture. It is not generally practical to fit for multiple species. Therefore, it is imperative to have adequate resolution to avoid partial volume effects. The boundary between myocardium and blood cavity may be significantly blurred due to through-plane effects of a relatively thick slice (≈8 mm), and will also be blurred in-plane due to the distortion of the imaging point spread function. Additional loss of resolution may occur due to cardiac motion during the imaging period particularly at high heart rates or for subjects with RR variability, or due to residual uncorrected respiratory motion. The net result is that it may not be possible to make accurate measurements if the myocardial wall is thin. Caution must be exercised to avoid partial volume problems, and to recognize their potential to bias studies of subjects with thin walls or higher heart rates. It has been proposed to measure T1-values in the mid-wall region  or to define the myocardial border after eroding the contour between blood and myocardium . Both of these recommendations are sound but still may result in bias due to contamination of the myocardial signal by blood.
Since the MT effect in inversion recovery is dominated by the MT tissue parameters more than protocol and scanner adjustments, it does not, in general, lead to reproducibility problems. As a result, the apparent T1 measured using MOLLI is highly reproducible despite significantly underestimating the T1 of the free pool [34, 50]. The MT effect in the blood is greatly reduced since the bound pool fraction is much smaller [52–54]. The effect of MT with contrast enhanced myocardium is not well studied. Many myocardial T1-mapping methods are validated using phantoms in comparison with standards such as spin echo with a long repetition time, however, the MT effects for phantoms are generally negligible for low concentration gels typically used.
The influence of random noise on the precision of various methods may be compared using Monte-Carlo methods. Other influences such as center frequency, which may in fact vary from study to study, will affect reproducibility but are not considered in the analysis of precision due to random noise. Precision depends on the SNR of the raw images and the number and location of samples along the recovery curve. Although equations for parameter error may provide insight into how the individual parameters affect precision , Monte-Carlo simulations provide a more straightforward means of comparing sampling strategies and protocols.
The heterogeneity of tissue ranges from focal to globally diffuse disease and associated T1 abnormality. Given adequate precision, the strength of pixel-wise mapping of T1 is the ability to detect small abnormalities and discriminate spatial structures.
In addition to the factors that influence accuracy and precision, a key limitation is the spatial resolution and the associated partial volume effects, particularly at myocardium-blood and myocardium-fat boundaries. The partial volume effect is dependent on the slice thickness as well as the in-plane resolution. Improved in-plane resolution and decreased slice thickness may be obtained at a sacrifice of SNR. The optimal trade-off has not been determined. Loss of resolution due to cardiac motion blur may result from longer imaging segments and/or imaging during periods of motion. To some extent, T1-mapping error maps can serve as a quality control metric to indicate the presence of poor fitting due to motion . By recognizing the error, it may be possible to adjust the timing or protocol for improved temporal resolution to mitigate motion. Similarly, respiratory motion is unavoidable in clinical practice, even with breath-holding. Respiratory motion correction can be used to mitigate errors to some extent, but residual uncorrected respiratory motion is still problematic, particularly if unrecognized .
Artifacts are commonplace in CMR however skilled clinicians are often capable of “reading through” these. Artifacts in quantitative parametric maps are less familiar and recognizing these artifacts will require experience. In addition to motion related artifacts, spatial variation in off-resonance due to B0-field inhomogeneity may lead to artifactual appearance of the T1-map. These may be particularly significant if the subject has devices implanted. Field maps may be acquired as a quality metric  but this requires additional data acquisition and some technical expertise from the clinician interpreting the study. In an ideal setting, a complete set of T1, T2, B0, B1+, and water/fat separated images would be acquired for comprehensive tissue characterization, but the acquisition time for all these datasets may be prohibitive.
Saturation recovery schemes such as SASHA that acquire a large number of measurements at short measurement times (<RR) are particularly prone to artifacts since these early images generally have lower SNR. For instance, residual parallel imaging artifacts will have a more significant effect on SASHA acquisition than MOLLI. The same can be said for artifacts related to blood flow. Edge artifacts are also more significant when using higher flip angle excitation, which leads to a distortion of the point spread function due to the transient weighting of k-space during the approach to steady state.
T1 relaxation is dependent on the field strength  with a significant increase in T1 from 1.5 T to 3 T field strength. Average native T1 values for normal myocardium measured using inversion recovery are reported to be 962 ± 25 ms at 1.5 T  and 1315 ± 39 ms at 3 T . While these values depend on the specific protocols, the field dependence is clearly exhibited. Higher field strength (3 T vs 1.5 T) has some pros and cons for quantifying myocardial T1. A disadvantage of the higher field strength is a greater inhomogeneity of both B0 and B1+ fields, which introduce variations in the apparent T1. However, the higher field strength provides an increased SNR, which may be traded off for decreased errors associated with B0 and B1+ variation by decreasing the SSFP excitation flip angle. A flip angle of 20° for MOLLI based protocols is recommended for 3 T, whereas 35° is widely used at 1.5 T. The SASHA method typically uses a FA = 70° at 1.5 T but is limited to 40°-45° at 3 T due to SAR constraints which significantly decreases the SNR. The myocardial T2 at 3 T is decreased relative to 1.5 T, which introduces greater T1 underestimation due to influence of SSFP readout as well as inversion efficiency. Longer duration RF pulses are generally used at 3 T to reduce SAR thereby increasing the echo spacing, which has negative implications for temporal resolution of single shot imaging particularly for subjects with higher heart rates. Despite challenges of higher field strength for quantifying myocardial tissue T1, mapping at 3 T has been demonstrated to differentiate diffuse disease from normal tissue in clinical studies .
Contrast exchange mechanisms
A number of questions remain to be studied in greater detail. It is important to develop a deeper understanding of the multi-compartment exchange between Gd contrast and the various tissue compartments intracellular, interstitium, and vascular, and the magnetization transfer parameters for exchange between the restricted and free pools in myocardial and blood tissue. These exchange mechanisms influence the accuracy of the T1-measurements and the calculation of extra-cellular volume (ECV) fraction using combined measurement of native T1 and T1 with exogenous contrast. The relative value of native T1 and ECV is a question that is still debated. The magnitude of error in ECV measurement due to intercompartmental exchange mechanisms during Gd washout may not be significant in a clinical context [9, 15, 55, 56].
A number of factors have been described that influence the accuracy of T1-mapping. If these factors, which may depend on the protocol or scanner adjustments, are not well controlled, then they can contribute to reduced reproducibility. If these factors are well controlled then the absolute accuracy may be less important and the “apparent” measured T1 might serve as a powerful clinical tool despite the fact that the measurement may not be fully understood. The issue of what is being measured and how it is best used to detect disease is a subject of on-going research at many institutions.
Summary of pros and cons of various reported T1-mapping protocols
Few image artifacts
A number of recent studies have shown the sensitivity of T1- and ECV-mapping for detection of disease with diffuse processes involving edema and or fibrosis affecting the interstitium. Many of these studies are population based studies which have demonstrated a correlation between small changes in T1 or ECV with disease or outcomes. T1 and ECV measures have been shown to have important prognostic significance. Quantification has the potential for an objective measurement to detect changes in disease over time or in response to therapy. Translating these exciting results to the reliable diagnosis of individuals where it may impact patient management still has technical challenges. In order to base diagnostic assessments on subtle changes in parameters, the demand for improved reproducibility and measures of confidence are much greater than for population based studies.
Inversion recovery methods such as MOLLI have excellent precision and are highly reproducible when using tightly controlled protocols. The MOLLI method is widely available and is relatively mature. The accuracy of inversion recovery techniques is affected significantly by MT. Despite this, the estimate of apparent inversion recovery time is a sensitive measure, which has been demonstrated to be a useful tool in characterizing tissue and discriminating disease. Saturation recovery methods have the potential to provide a more accurate measurement of T1 that is less sensitive to MT as well as other factors. Saturation recovery techniques are noisier and somewhat more artifact prone and have not demonstrated the same level of reproducibility at this point in time.
A key limitation of T1-mapping for clinical application is the error due to partial volume contamination from blood, which is significant for thin walled structures. Caution must be exercised to ensure adequate spatial resolution is obtained and to recognize less familiar artifacts in parametric maps.
- Moon JC, Messroghli DR, Kellman P, Piechnik SK, Robson MD, Ugander M, Gatehouse PD, Arai AE, Friedrich MG, Neubauer S, Schulz-Menger J, Schelbert EB: Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson. 2013, 15: 92-10.1186/1532-429X-15-92.PubMed CentralView ArticlePubMedGoogle Scholar
- Wong TC, Piehler K, Meier CG, Testa SM, Klock AM, Aneizi AA, Shakesprere J, Kellman P, Shroff SG, Schwartzman DS, Mulukutla SR, Simon MA, Schelbert EB: Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Circulation. 2012, 126 (10): 1206-16. 10.1161/CIRCULATIONAHA.111.089409.PubMed CentralView ArticlePubMedGoogle Scholar
- Wong TC, Piehler KM, Kang IA, Kadakkal A, Kellman P, Schwartzman DS, Mulukutla SR, Simon MA, Shroff SG, Kuller LH, Schelbert EB: Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. Eur Heart J. 2013, doi: 10.1093/eurheartj/eht193Google Scholar
- Pennell DJ, Sechtem UP, Higgins CB: Clinical indications for cardiovascular magnetic resonance (CMR): consensus panel report. Eur Heart J. 2004, 25: 1940-65. 10.1016/j.ehj.2004.06.040.View ArticlePubMedGoogle Scholar
- Hunold P, Schlosser T, Vogt FM: Myocardial late enhancement in contrast-enhanced cardiac MRI: distinction between infarction scar and non-infarction-related disease. Am J Roentgenol. 2005, 184 (5): 1420-6. 10.2214/ajr.184.5.01841420.View ArticleGoogle Scholar
- Sado DM, Flett AS, Moon JC: Novel imaging techniques for diffuse myocardial fibrosis. Future Cardiol. 2011, 7 (5): 643-50. 10.2217/fca.11.45.View ArticlePubMedGoogle Scholar
- Mewton N, Liu CY, Croisille P, Bluemke D, Lima JA: Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol. 2011, 57 (8): 891-903. 10.1016/j.jacc.2010.11.013.View ArticlePubMedGoogle Scholar
- Gai N, Turkbey EB, Nazarian S: T1 mapping of the gadolinium- enhanced myocardium: adjustment for factors affecting interpatient comparison. Magn Reson Med. 2011, 65 (5): 1407-15. 10.1002/mrm.22716.PubMed CentralView ArticlePubMedGoogle Scholar
- Lee JJ, Liu S, Nacif MS, Ugander M, Kawel N, Sibley CT, Kellman P, Arai A, Bluemke DA: Myocardial T1 and extracellular volume fraction mapping at 3 tesla. J Cardiovasc Magn Reson. 2011, 13 (1): 75-10.1186/1532-429X-13-75.PubMed CentralView ArticlePubMedGoogle Scholar
- Arheden H, Saeed M, Higgins CB: Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar mr imaging to quantify myocardial infarction: comparison with 99mtc-dtpa autoradiography in rats. Radiology. 1999, 211: 698-708. 10.1148/radiology.211.3.r99jn41698.View ArticlePubMedGoogle Scholar
- Jerosch-Herold M, Sheridan DC, Kushner JD: Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Am J Physiol Heart Circ Physiol. 2008, 295: H1234-42. 10.1152/ajpheart.00429.2008.PubMed CentralView ArticlePubMedGoogle Scholar
- Flett AS, Hayward MP, Ashworth MT: Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation. 2010, 122 (2): 138-44. 10.1161/CIRCULATIONAHA.109.930636.View ArticlePubMedGoogle Scholar
- Kehr E, Sono M, Chugh S, Jerosch-Herold M: Gadolinium-enhanced magnetic resonance imaging for detection and quantification of fibrosis in human myocardium in vitro. Int J Cardiovasc Imaging. 2008, 24: 61-8.View ArticlePubMedGoogle Scholar
- Broberg CS, Chugh S, Conklin C, Sahn DJ, Jerosch-Herold M: Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease. Circ Cardiovasc Imaging. 2010, 3: 727-34. 10.1161/CIRCIMAGING.108.842096.PubMed CentralView ArticlePubMedGoogle Scholar
- Schelbert E, Testa SM, Meier CG: Myocardial extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus. J Cardiovasc Magn Reson. 2011, 13: 16-10.1186/1532-429X-13-16.PubMed CentralView ArticlePubMedGoogle Scholar
- Ugander M, Oki AJ, Hsu L-Y: Extracellular volume imaging by MRI provides insight into overt and subclinical myocardial pathology. Eur Heart J. 2012, 33 (10): 1268-78. 10.1093/eurheartj/ehr481.PubMed CentralView ArticlePubMedGoogle Scholar
- Kellman P, Wilson JR, Xue H, Bandettini WP, Shanbhag SM, Druey KM, Ugander M, Arai AE: Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience. J Cardiovasc Magn Reson. 2012, 14: 64-10.1186/1532-429X-14-64.PubMed CentralView ArticlePubMedGoogle Scholar
- Puntmann VO, Voigt T, Chen Z, Mayr M, Karim R, Rhode K, Pastor A, Carr-White G, Razavi R, Schaeffter T, Nagel E: Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging. 2013, 6: 475-84. 10.1016/j.jcmg.2012.08.019.View ArticlePubMedGoogle Scholar
- Messroghli DR, Niendorf T, Schulz-Menger J, Dietz R, Friedrich MG: T1 mapping in patients with acute myocardial infarction. J Cardiovasc Magn Reson. 2003, 5: 353-9. 10.1081/JCMR-120019418.View ArticlePubMedGoogle Scholar
- Messroghli DR, Walters K, Plein S, Sparrow P, Friedrich MG, Ridgway JP, Sivananthan MU: Myocardial T1 mapping: application to patients with acute and chronic myocardial infarction. Magn Reson Med. 2007, 58: 34-40. 10.1002/mrm.21272.View ArticlePubMedGoogle Scholar
- Ugander M, Bagi PS, Oki AJ: Myocardial edema as detected by pre-contrast T1 and T2 MRI delineates area at risk associated with acute myocardial infarction. JACC Cardiovasc Imaging. 2012, 5 (6): 596-603. 10.1016/j.jcmg.2012.01.016.PubMed CentralView ArticlePubMedGoogle Scholar
- Ferreira VM, Piechnik SK, Dall’Armellina E, Karamitsos TD, Francis JM, Choudhury RP, Friedrich MG, Robson MD, Neubauer S: Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2012, 14: 42-10.1186/1532-429X-14-42.PubMed CentralView ArticlePubMedGoogle Scholar
- Dall’Armellina E, Piechnik SK, Ferreira VM, Si QL, Robson MD, Francis JM, Cuculi F, Kharbanda RK, Banning AP, Choudhury RP, Karamitsos TD, Neubauer S: Cardiovascular magnetic resonance by non contrast T1-mapping allows assessment of severity of injury in acute myocardial infarction. J Cardiovasc Magn Reson. 2012, 14: 15-10.1186/1532-429X-14-15.PubMed CentralView ArticlePubMedGoogle Scholar
- Ferreira VM, Piechnik SK, Dall’armellina E, Karamitsos TD, Francis JM, Ntusi N, Holloway C, Choudhury RP, Kardos A, Robson MD, Friedrich MG, Neubauer S: T1 mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. JACC Cardiovasc Imaging. 2013, doi:10.1016/j.jcmg.2013.03.008 [Epub ahead of print]Google Scholar
- Karamitsos TD, Piechnik SK, Banypersad SM, Fontana M, Ntusi NB, Ferreira VM, Whelan CJ, Myerson SG, Robson MD, Hawkins PN, Neubauer S, Moon JC: Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging. 2013, 6: 488-97. 10.1016/j.jcmg.2012.11.013.View ArticlePubMedGoogle Scholar
- Puntmann VO, D’Cruz D, Smith Z, Pastor A, Choong P, Voigt T, Carr-White G, Sangle S, Schaeffter T, Nagel E: Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus. Circ Cardiovasc Imaging. 2013, 6: 295-301. 10.1161/CIRCIMAGING.112.000151.View ArticlePubMedGoogle Scholar
- Sado DM, White SK, Piechnik SK, Banypersad SM, Treibel T, Captur G, Fontana M, Maestrini V, Flett AS, Robson MD, Lachmann RH, Murphy E, Mehta A, Hughes D, Neubauer S, Elliott PM, Moon JC: The identification and assessment of Anderson Fabry disease by cardiovascular magnetic resonance non-contrast myocardial T1 mapping. Circ Cardiovasc Imaging. 2013, 6: 392-8.View ArticlePubMedGoogle Scholar
- Pedersen SF, Thrysoe SA, Robich MP, Paaske WP, Ringgaard S, Botker HE, Hansen ES, Kim WY: Assessment of intramyocardial hemorrhage by T1-weighted cardiovascular magnetic resonance in reperfused acute myocardial infarction. J Cardiovasc Magn Reson. 2012, 14: 59-10.1186/1532-429X-14-59.PubMed CentralView ArticlePubMedGoogle Scholar
- Feng Y, He T, Carpenter J-P, Jabbour A, Alam MH, Gatehouse PD, Greiser A, Messroghli D, Firmin DN, Pennell DJ: In vivo comparison of myocardial T1 with T2 and T2* in thalassaemia major. J Magn Reson Imaging. 2013, 38: 588-93. 10.1002/jmri.24010.View ArticlePubMedGoogle Scholar
- Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, Kaye DM, Taylor AJ: Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol. 2008, 52: 1574-80. 10.1016/j.jacc.2008.06.049.View ArticlePubMedGoogle Scholar
- Flacke SJ, Fischer SE, Lorenz CH: Cardiac imaging abbreviations: gadopentetate dimeglumine partition coefficient in human myocardium in vivo: normal distribution and elevation in acute and chronic infarction. Radiology. 2001, 218: 703-710. 10.1148/radiology.218.3.r01fe18703.View ArticlePubMedGoogle Scholar
- Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP: Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med. 2004, 52: 141-6. 10.1002/mrm.20110.View ArticlePubMedGoogle Scholar
- Piechnik SK, Ferreira VM, Dall’Armellina E, Cochlin LE, Greiser A, Neubauer S, Robson MD: Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson. 2010, 12: 69-10.1186/1532-429X-12-69.PubMed CentralView ArticlePubMedGoogle Scholar
- Kellman P, Wilson JR, Xue H, Ugander M, Arai AE: Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method. J Cardiovasc Magn Reson. 2012, 14: 63-10.1186/1532-429X-14-63.PubMed CentralView ArticlePubMedGoogle Scholar
- Xue H, Shah S, Greiser A: Motion correction for myocardial T1 mapping using image registration with synthetic image estimation. Magn Reson Med. 2012, 67 (6): 1644-55. 10.1002/mrm.23153.PubMed CentralView ArticlePubMedGoogle Scholar
- Xue H, Greiser A, Zuehlsdorff S, Jolly MP, Guehring J, Arai AE, Kellman P: Phase-sensitive inversion recovery for myocardial T(1) mapping with motion correction and parametric fitting. Magn Reson Med. 2013, 69 (5): 1408-20. 10.1002/mrm.24385.PubMed CentralView ArticlePubMedGoogle Scholar
- Messroghli DR, Greiser A, Frohlich M, Dietz R, Schulz-Menger J: Optimization and validation of a fully-integrated pulse sequence for modified look- locker inversion-recovery (MOLLI) T1mapping of the heart. J Magn Reson Imaging. 2007, 26: 1081-6. 10.1002/jmri.21119.View ArticlePubMedGoogle Scholar
- Gai ND, Stehning C, Nacif M, Bluemke D: Modified Look-Locker T(1) evaluation using Bloch simulations: human and phantom validation. Magn Reson Med. 2013, 69 (2): 329-336. 10.1002/mrm.24251.View ArticlePubMedGoogle Scholar
- Salerno M, Janardhanan R, Jiji RS, Brooks J, Adenaw N, Mehta B, Yang Y, Antkowiak P, Kramer CM, Epstein FH: Comparison of methods for determining the partition coefficient of gadolinium in the myocardium using T(1) mapping. J Magn Reson Imaging. 2013, 38 (1): 217-224. 10.1002/jmri.23875.PubMed CentralView ArticlePubMedGoogle Scholar
- Kellman P, Herzka DA, Hansen MS: Adiabatic inversion pulses for myocardial T1-mapping. Magn Res Med. 2013, doi:10.1002/mrm.24793. [Epub ahead of print]Google Scholar
- Kellman P, Arai AE, Xue H: T1 and extracellular volume mapping in the heart: estimation of error maps and the influence of noise on precision. J Cardiovasc Magn Reson. 2013, 15: 56-10.1186/1532-429X-15-56.PubMed CentralView ArticlePubMedGoogle Scholar
- Kellman P, Herzka DA, Arai AE, Hansen MS: Influence of Off-resonance in myocardial T1-mapping using SSFP based MOLLI method. J Cardiovasc Magn Reson. 2013, 15: 63-10.1186/1532-429X-15-63.PubMed CentralView ArticlePubMedGoogle Scholar
- Higgins DM, Ridgway JP, Radjenovic A, Sivananthan UM, Smith MA: T1 measurement using a short acquisition period for quantitative cardiac applications. Med Phys. 2005, 32: 1738-10.1118/1.1921668.View ArticlePubMedGoogle Scholar
- Chow K, Flewitt JA, Green JD, Pagano JJ, Friedrich MG, Thompson RB: Saturation recovery single-shot acquisition (SASHA) for myocardial T1 mapping. Magn Reson Med. 2013, doi: 10.1002/mrm.24878. [Epub ahead of print]Google Scholar
- Weingärtner S, Akçakaya M, Basha T, Kissinger KV, Goddu B, Berg S, Manning WJ, Nezafat R: Combined saturation/inversion recovery sequences for improved evaluation of scar and diffuse fibrosis in patients with arrhythmia or heart rate variability. Magn Reson Med. 2013, doi: 10.1002/mrm.24761. [Epub ahead of print]Google Scholar
- Deichmann R, Haase A: Quantification of Tl Values by SNAPSHOT-FLASH NMR Imaging. J Magn Reson. 1992, 612: 608-12.Google Scholar
- Schmitt P, Griswold MA, Jakob PM, Kotas M, Gulani V, Flentje M, Haase A: Inversion recovery TrueFISP: quantification of T(1), T(2), and spin density. Magn Reson Med. 2004, 51: 661-667. 10.1002/mrm.20058.View ArticlePubMedGoogle Scholar
- Song T, Stainsby JA, Ho VB, Hood MN, Slavin GS: Flexible cardiac T1 mapping using a modified Look-Locker acquisition with saturation recovery. Magn Reson Med. 2012, 67: 622-627. 10.1002/mrm.24137.View ArticlePubMedGoogle Scholar
- Sung K, Nayak KS: Design and use of tailored hard-pulse trains for uniformed saturation of myocardium at 3 Tesla. Magn Reson Med. 2008, 60: 997-1002. 10.1002/mrm.21765.View ArticlePubMedGoogle Scholar
- Piechnik SK, Ferreira VM, Lewandowski AJ, Ntusi NAB, Banerjee R, Holloway C, Hofman MBM, Sado DM, Maestrini V, White SK, Lazdam M, Karamitsos T, Moon JC, Neubauer S, Leeson P, Robson MD: Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI. J Cardiovasc Magn Reson. 2013, 15: 13-10.1186/1532-429X-15-13.PubMed CentralView ArticlePubMedGoogle Scholar
- Robson MD, Piechnik SK, Tunnicliffe EM, Neubauer S: T1 measurements in the human myocardium: the effects of magnetization transfer on the SASHA and MOLLI sequences. Magn Reson Med. 2013, 670: 664-70.View ArticleGoogle Scholar
- Dousset V, Degreze P, Mieze S, Sessay M, Basse-Cathalinat B, Caille J-M: Magnetization transfer on in vitro circulating blood: implications for time-of-flight angiography. JMRI. 1995, 5: 786-8. 10.1002/jmri.1880050630.View ArticlePubMedGoogle Scholar
- Hernandez-Garcia L, Lewis DP, Moffat B, Branch CA: Magnetization transfer effects on the efficiency of flow-driven adiabatic fast passage inversion of arterial blood. NMR Biomed. 2007, 20: 733-42. 10.1002/nbm.1137.PubMed CentralView ArticlePubMedGoogle Scholar
- Pike GB, Hu BS, Glover GH, Enzmann DR: Magnetization transfer time-of-flight magnetic resonance angiography. Magn Reson Med. 1992, 25: 372-9. 10.1002/mrm.1910250217.View ArticlePubMedGoogle Scholar
- Miller CA, Naish JH, Bishop P, Coutts G, Clark D, Zhao S, Ray SG, Yonan N, Williams SG, Flett AS, Moon JC, Greiser A, Parker GJM, Schmitt M: Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Circ Cardiovasc Imaging. 2013, 6: 373-83.View ArticlePubMedGoogle Scholar
- Kawel N, Nacif M, Zavodni A, Jones J, Liu S, Sibley CT, Bluemke DA: T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA. J Cardiovasc Magn Reson. 2012, 14: 26-10.1186/1532-429X-14-26.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.